Akums Drugs and Pharmaceuticals Limited

Akums Drugs and Pharmaceuticals Limited (AKUMS) is a small-cap Healthcare company valued at ₹11,506 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Akums Drugs and Pharmaceuticals Limited last traded at ₹731, down 2.51% on the day.

Recent developments

On 2026-07-03, the company announced a dividend of ₹3.00 per share, ex-date. Promoter holding remained at 75.26% as of 2026-06-30, while domestic institutional holding dropped 0.91 percentage points and foreign institutional holding rose 0.54 percentage points in the quarter.

Financial performance

The company's annual revenue rose 5.9% to ₹4,359 crore, while annual net profit fell 25.5% to ₹256 crore. The latest quarter saw revenue increase 13.9% year-over-year to ₹1,167 crore, and net profit surged 55.4% to ₹101 crore, indicating improving profitability in recent months.

Valuation multiples

The stock trades at 43.9 times earnings, a premium to the Healthcare median of 32.0, 3.56 times book value. It yields 0.4%.

Things to watch

Net profit margin narrowed 2.5 percentage points to 5.9%, and return on equity fell to 7.7% from 8.4% in the prior year. The stock is 3.1% below its 52-week high, and profit declined 25.5% annually despite revenue growth.

Where it stands

The company ended the latest quarter with net profit of ₹101 crore, up 55.4% from the same quarter a year earlier, while annual net profit fell 25.5% to ₹256 crore. The stock is 3.1% below its 52-week high, and net profit margin is now 5.9%.

Summarised by DocStoX's model on 2026-10-03 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.